NDC product
Hyperactivity-Mental Focus
NDC 55714-2579 · Newton Laboratories, Inc.
Key facts
| Product NDC | 55714-2579 |
|---|---|
| Proprietary name | Hyperactivity-Mental Focus |
| Nonproprietary name | Adrenalinum, Aconitum nap., Arg. nit., Arsenicum alb., Baptisia, Chamomilla, Cypripedium, Digitalis, Gelsemium, Humulus, Ignatia, Impatiens glandulifera flos and 13 more |
| Substances | SCUTELLARIA LATERIFLORA WHOLE, DELPHINIUM STAPHISAGRIA SEED, DATURA STRAMONIUM, THERIDION CURASSAVICUM, ECHINACEA, UNSPECIFIED, GINKGO, HYPERICUM PERFORATUM, PASSIFLORA INCARNATA FLOWERING TOP, EPINEPHRINE, ACONITUM NAPELLUS, SILVER NITRATE, ARSENIC TRIOXIDE and 13 more |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Newton Laboratories, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE] and 10 more |
| Marketing start | Jul 3, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: